![](/img/cover-not-exists.png)
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study
Nagao, Shoji, Nishio, Shin, Okada, Satoshi, Otsuki, Takeo, Fujiwara, Kiyoshi, Tanabe, Hiroshi, Takano, Masashi, Hasumi, Yoko, Takei, Yuji, Hasegawa, Tetsuya, Matsumoto, Takashi, Fujiwara, Keiichi, TakVolume:
76
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2793-9
Date:
August, 2015
File:
PDF, 468 KB
english, 2015